Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-02-22 Option Award | 2024-02-26 6:00 pm | N/A 2034-02-21 | Ovid Therapeutics Inc. | OVID | Perone Thomas Michael General Counsel, Secretary | 196,875 | $0 | 196,875 (Direct) | View |
| 2023-02-23 Option Award | 2023-02-27 5:00 pm | N/A 2033-02-22 | Ovid Therapeutics Inc. | OVID | Perone Thomas Michael General Counsel, Secretary | 175,000 | $0 | 175,000 (Direct) | View |
| 2022-04-08 Option Award | 2022-04-12 5:30 pm | N/A 2032-04-07 | Ovid Therapeutics Inc. | OVID | Perone Thomas Michael General Counsel, Secretary | 35,399 | $0 | 35,399 (Direct) | View |
| 2022-02-03 Option Award | 2022-02-04 6:19 pm | N/A 2032-02-02 | Ovid Therapeutics Inc. | OVID | Perone Thomas Michael General Counsel, Secretary | 175,000 | $0 | 175,000 (Direct) | View |
| 2020-11-25 Option Award | 2021-04-29 5:32 pm | 2020-11-25 2030-05-04 | Ovid Therapeutics Inc. | OVID | Perone Thomas Michael General Counsel, Secretary | 44,000 | $0 | 44,000 (Direct) | View |
| 2020-12-17 Option Award | 2020-12-21 5:04 pm | N/A 2030-12-16 | Ovid Therapeutics Inc. | OVID | Perone Thomas Michael General Counsel, Secretary | 175,000 | $0 | 175,000 (Direct) | View |
| 2020-10-11 Option Award | 2020-10-13 4:38 pm | N/A 2030-10-10 | Ovid Therapeutics Inc. | OVID | Perone Thomas Michael General Counsel, Secretary | 20,000 | $0 | 20,000 (Direct) | View |
| 2020-01-01 Option Award | 2020-01-02 7:47 pm | N/A 2030-12-31 | Ovid Therapeutics Inc. | OVID | Perone Thomas Michael General Counsel, Secretary | 75,000 | $0 | 75,000 (Direct) | View |
| 2019-12-18 Option Award | 2019-12-20 4:18 pm | N/A 2029-12-17 | Ovid Therapeutics Inc. | OVID | Perone Thomas Michael SVP, General Counsel | 100,000 | $0 | 100,000 (Direct) | View |